Anzeige
Mehr »
Login
Donnerstag, 09.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
536 Leser
Artikel bewerten:
(2)

Tim Grant, CEO of Deus X Capital and Former Galaxy Executive, Joins Hilbert Group Board

Finanznachrichten News

STOCKHOLM, SWEDEN / ACCESSWIRE / October 10, 2023 / Hilbert Group (STO:HILB-B)(FRA:999) Hilbert Group AB, the Nasdaq First North listed investment firm (ticker Hilb B) specializing in quantitative trading in digital asset markets, will appoint Tim Grant to the board in accordance with a proposal by the founders of Hilbert Group who control approx. 62 percent of the votes in the company.

Tim Grant recently became CEO of Deus X Capital, a newly launched $1 billion investment and operating company focused on private equity, venture capital, venture building and fund allocation in the digital asset, blockchain, fintech and institutional capital markets sectors. Deus X Capital is a shareholder in Hilbert Group and Deus X CIO, Stuart Connolly, is already a member of the Board of Directors in Hilbert Group AB. Tim and Stuart are also Chairman and CEO, respectively, of Alpha Lab 40, an institutional-grade digital asset market maker and liquidity provider.

Tim has a distinguished background and brings deep experience in both traditional finance and the blockchain/crypto industry. Prior to co-founding Deus X, he was Head of EMEA at Galaxy Digital, a leading investor and operator in the digital asset ecosystem with assets under management of more than $2.3 billion. Other roles Tim has held include CEO of SIX Digital Exchange, Founder and CEO of DrumG Technologies and Managing Director at both UBS Investment Bank and UBS O'Connor, the multi-strategy hedge fund.

"Since 2017, Hilbert's focus has been to attract the industry's best talent; as such, we are incredibly excited for Tim to join our board," said Dr. Niclas Sandström, Hilbert Group's CEO. "Tim has significant experience at a senior level on both the sell-side and buy-side, a track record of building and leading successful blockchain businesses, and is an industry thought-leader. We look forward to working with Tim as we continue to capitalize on our sustained growth and further position Hilbert as a leading digital assets investment solutions provider for institutional investors."

Speaking on his appointment, Tim said: "Institutionalization of the digital asset space is gaining momentum and I strongly believe that Hilbert Group is on its way to becoming a leading international investment and trading firm servicing institutional investors. Hilbert stands out as one of the very best firms in terms of investment process, operational excellence and corporate governance and I very much look forward to working with the Board of Directors and the management team to realise the significant potential."

Hilbert Group's intention is to convene an EGM in November at which Tim Grant will be elected to the Board of Directors.

About Deus X

Deus X is a specialist investment and operating company focused on private equity, venture capital, and venture build opportunities in the capital markets, fintech and digital assets sectors. Deus X leverages its unique expertise, extensive network, and diverse capabilities to foster lasting value within the financial technology sector. Deus X invests globally and has a presence in Malta, London and the UAE.

For more information, visit: www.deusx.capital.

About Us

Hilbert group is a quantitative investment company specializing in algorithmic trading strategies in digital asset markets.

Hilbert Group is a Swedish public company and is committed to providing operational infrastructure, risk management and corporate governance that meets the ever-increasing demands of institutional investors.

Hilbert Group is listed on Nasdaq First North Growth Market (ticker HILB B) with Eminova Fondkommission (phone +46 8 684 211 10 | adviser@eminova.se ) as Certified Adviser.

For more information, visit: www.hilbert.group

Attachments

Tim Grant, CEO of Deus X Capital and Former Galaxy Executive, Joins Hilbert Group Board

SOURCE: Hilbert Group

View source version on accesswire.com:
https://www.accesswire.com/791530/tim-grant-ceo-of-deus-x-capital-and-former-galaxy-executive-joins-hilbert-group-board

© 2023 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.